Search

Your search keyword '"TORTORA, GIAMPAOLO"' showing total 2,007 results

Search Constraints

Start Over You searched for: Author "TORTORA, GIAMPAOLO" Remove constraint Author: "TORTORA, GIAMPAOLO"
2,007 results on '"TORTORA, GIAMPAOLO"'

Search Results

151. Evaluation of PBRM1, PD-L1, CD31, and CD4/CD8 ratio as a predictive signature of response to VEGFR-TKI–based therapy in patients with metastatic renal cell carcinoma (mRCC) with IMDC intermediate prognosis: Results from the APAChE-I Study.

153. Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies

154. Maintenance strategies after anti–EGFR-based induction in RAS wild-type (wt) metastatic colorectal cancer (mCRC): A systematic review and Bayesian network meta-analysis.

155. Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis

156. Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma

157. Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: A systematic review and meta-analysis.

158. Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival

163. Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

164. Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma

165. Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients

166. Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials

167. Chemotherapy Rechallenge or Reintroduction, Regorafenib and Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A PROpensity ScorE Analysis of Treatment Beyond Second Line (PROSERpYNa Study)

168. Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy

170. Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel

171. Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis

173. A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants

174. Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)

175. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

176. An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis

178. CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer

179. Safety and efficacy of EUS-guided radiofrequency ablation for unresectable pancreatic insulinoma: a single-center experience

180. The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy

181. 1093 A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer

182. Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?

183. Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics

184. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

185. sj-docx-2-tam-10.1177_17588359221138657 – Supplemental material for Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy

186. sj-docx-1-tam-10.1177_17588359231173180 – Supplemental material for Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials

187. sj-docx-1-tam-10.1177_17588359221138657 – Supplemental material for Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy

188. Combined burden and functional impact tests for cancer driver discovery using DriverPower

189. Integrative pathway enrichment analysis of multivariate omics data

190. Pathway and network analysis of more than 2500 whole cancer genomes

191. Divergent mutational processes distinguish hypoxic and normoxic tumours

192. Genomic footprints of activated telomere maintenance mechanisms in cancer

193. Rare Secondary Tumors of the Pancreas

196. Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

197. Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer

198. Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center

199. Transcriptomic dissection of Intraepithelial Papillary Mucinous Neoplasms progression by spatial technologies identified novel markers of pancreatic carcinogenesis

200. Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib

Catalog

Books, media, physical & digital resources